Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA Capital. In 2002 he broke even when the S&P 500 index lost 22%. By the end of 2003, the initial $4 Million investment became $13 Million. Boston-based RA Capital invests in companies with promising drugs and technologies.
| Fund Name: | RA Capital Management |
| Manager | Peter Kolchinsky |
| Portfolio Value | $1,540,247,000 |
| Change This QTR | +1.18% |
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1. | Wave Life Sciences Ltd | 7,512,049 | $287,336 | 18.65% | ||
| 2. | ASND | 4,240,536 | $282,080 | 18.31% | ||
| 3. | Solid Biosciences Inc | 2,689,444 | $95,825 | 6.22% | ||
| 4. | ECYT | 5,649,884 | $77,968 | +46% | 5.06% | |
| 5. | MNTA | 3,702,533 | $75,717 | 4.91% |
| Company | Symbol | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2018-10-05 | ||||
| 2018-08-06 | ||||
| 2018-07-10 | ||||
| 2018-07-02 |
We use tracking technologies to enhance your user experience and to provide you service. By using Insider Monkey, you are giving us consent. Learn More
